(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EMZELBI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EMZELBI

ST13

US500000079313584

Class

5

Filing

79313584

Registration

7203745

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

10/31/2023

Trademark type

Word

Nice classes

5

Filing date

04/30/2021

Registration date

10/31/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/31/2023

Last transaction

10/31/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

OH, HYUN-JUNG

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

37 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/31/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/31/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/15/2023

PUBO

PUBLISHED FOR OPPOSITION

08/15/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

08/13/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/26/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/26/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/16/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/19/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/19/2023

FINA

FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE

06/15/2022

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

06/15/2022

CRTP

REG. CANCELLED - RESTORED TO PENDENCY

03/09/2022

APET

ASSIGNED TO PETITION STAFF

03/09/2022

RCII

REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED

03/08/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

02/03/2022

ES7R

TEAS SECTION 7 REQUEST RECEIVED

01/31/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

01/04/2022

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

11/23/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/19/2021

PUBO

PUBLISHED FOR OPPOSITION

10/19/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/29/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/16/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/15/2021

DOCK

ASSIGNED TO EXAMINER

09/09/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/09/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/09/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/09/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/09/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/09/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/09/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/27/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/26/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/17/2021

Continuous trademark protection

Get notified about every new filing that threatens EMZELBI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.